This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Côté, R. Articles by Léger, B. Search for Related Content PubMed PubMed Citation Articles by Côté, R. Articles by Léger, B. Related Collections Carotid Stenosis Doppler ultrasound, Transcranial Doppler etc. Risk Factors for Stroke

(Stroke. 2000;31:1856.)
© 2000 American Heart Association, Inc.

Original Contributions

Hemostatic Markers in Patients at Risk of Cerebral Ischemia

Robert Côté, MD; Christina Wolfson, PhD; Susan Solymoss, MD; Ariane Mackey, MD; Jacques R Leclerc, MD; Denis Simard, MD; Fabrice Rouah, MSc; France Bourque, RN Barbara Léger, RN

From the Divisions of Neurology (R.C., F.B.) and Hematology (S.S., J.R.L.), Montreal General Hospital, and Department of Epidemiology and Biostatistics (C.W., F.R.), McGill University, Montreal, and the Division of Neurology, Hôpital de l’Enfant Jésus, Laval University, Quebec City (A.M., D.S., B.L.), Canada.

Background—Increased levels of markers of hemostasis may assist in the determination of the extent of carotid occlusive disease and the identification of neurologically intact individuals at increased risk of ischemic events.

Methods—We conducted a prospective study of 304 subjects, including 82 with a recent (7 days) transient ischemic attack (TIA), 157 asymptomatic individuals with a cervical bruit, and 65 control subjects. Baseline evaluation included a neurological assessment, ECG, cervical ultrasonography, and cerebral CT and/or MRI. Levels of markers of coagulation and fibrinolytic activity were also determined. Results were analyzed in relation to the degree of carotid disease and the subsequent occurrence of cerebral and cardiac ischemic events.

Results—Over a mean follow-up period of 2.8 years (SD, 1.3 years), 114 ischemic events occurred. Survival analyses showed that prothrombin fragment 1.2 (F_1.2) was a predictor of time to cerebral and cardiac ischemic events in the combined TIA and asymptomatic bruit group (relative risk [RR], 1.46; 95% CI, 1.18 to 1.81) as well as in the asymptomatic bruit group separately (RR, 1.70; 95% CI, 1.14 to 2.53). In the TIA group, both F_1.2 (RR, 2.36; 95% CI, 1.19 to 4.68) and severe (80%) carotid stenosis (RR, 3.53; 95% CI, 1.19 to 10.51) were predictive of time to ischemic stroke, myocardial infarction, or vascular death.

Conclusions—In patients with TIAs and in asymptomatic individuals with cervical bruits, F_1.2 levels were found to be independent predictors of subsequent cerebral and cardiac ischemic events. Our results are consistent with an active role of the coagulation system through upregulation of thrombin in carotid disease progression and in the pathogenesis of ischemic events in patients at risk.

Key Words: : cerebral ischemia • diagnosis • hemostasis • prognosis • stenosis

This article has been cited by other articles:

				J. D. Easton, J. L. Saver, G. W. Albers, M. J. Alberts, S. Chaturvedi, E. Feldmann, T. S. Hatsukami, R. T. Higashida, S. C. Johnston, C. S. Kidwell, et al. Definition and Evaluation of Transient Ischemic Attack: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke, June 1, 2009; 40(6): 2276 - 2293. [Abstract] [Full Text] [PDF]

				M. Di Napoli and P. Singh Is Plasma Fibrinogen Useful in Evaluating Ischemic Stroke Patients?: Why, How, and When Stroke, May 1, 2009; 40(5): 1549 - 1552. [Full Text] [PDF]

				N. Turgut, O. Akdemir, B. Turgut, M. Demir, G. Ekuklu, O. Vural, G. Ozbay, and U. Utku Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 15 - 20. [Abstract] [PDF]

				K. L. Furie, R. Rosenberg, J. L. Thompson, K. Bauer, J. P. Mohr, B. Rosner, R. Sciacca, S. Barzegar, B. Thornell, T. Costigan, et al. Thrombin generation in non-cardioembolic stroke subtypes: The Hemostatic System Activation Study Neurology, September 14, 2004; 63(5): 777 - 784. [Abstract] [Full Text] [PDF]